• Please log in or register to access this feature.

Efficacy and Safety of Intravenous Immunoglobulin as Adjuvant Treatment for Refractory Neuropathic Pain. Results of an Open-Label, Multicenter Study

  1. Stefano Jann MD1,*,
  2. Ada Francia MD2,
  3. Maria E. Fruguglietti MD1,
  4. Luisa De Toni Franceschini MD1,
  5. Roberto Sterzi MD1

Article first published online: 7 SEP 2012

DOI: 10.1111/j.1526-4637.2012.01478.x

Issue

Pain Medicine

Pain Medicine

Volume 13, Issue 10, pages 1334–1341, October 2012

Additional Information

How to Cite

Jann, S., Francia, A., Fruguglietti, M. E., De Toni Franceschini, L. and Sterzi, R. (2012), Efficacy and Safety of Intravenous Immunoglobulin as Adjuvant Treatment for Refractory Neuropathic Pain. Results of an Open-Label, Multicenter Study. Pain Medicine, 13: 1334–1341. doi: 10.1111/j.1526-4637.2012.01478.x

Author Information

  1. 1

    Department of Neurology, Niguarda Hospital, Milan

  2. 2

    Neurological Clinic, University La Sapienza, Rome, Italy

*Stefano Jann, MD, Department of Neurology, Azienda Ospedaliera, Ospedale Niguarda Ca' Granda, Piazza Ospedale Maggiore 3, 20162 Milano, Italia. Tel: +39 02 64442348; Fax: +39 02 64442819; E-mail: stefano.jann@ospedaleniguarda.it.

Publication History

  1. Issue published online: 15 OCT 2012
  2. Article first published online: 7 SEP 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS